Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections.
about
Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriersThe C-mer gene is induced by Epstein-Barr virus immediate-early protein BRLF1Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replicationEpstein-Barr Virus and Its Association with Oral Hairy Leukoplakia: A Short ReviewFunctional role of apoptosis in oral diseases: An updateEpstein-Barr virus latent genesThe B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1Hairy leukoplakia; lessons learned: 30-plus years.Latent membrane protein 1 deletion mutants accumulate in reed-sternberg cells of human immunodeficiency virus-related Hodgkin's lymphoma.Arsenic trioxide inhibits EBV reactivation and promotes cell death in EBV-positive lymphoma cells.Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1Latent membrane protein 1 is dispensable for Epstein-Barr virus replication in human embryonic kidney 293 cells.Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancerOral dysplasia and squamous cell carcinoma: correlation between increased expression of CD21, Epstein-Barr virus and CK19.The Epstein-Barr virus immediate-early protein BZLF1 induces both a G(2) and a mitotic blockVirus and cell RNAs expressed during Epstein-Barr virus replicationZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus.Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms.Efficient replication of Epstein-Barr virus in stratified epithelium in vitro.Mechanisms of expression of HHV8, EBV and HPV in selected HIV-associated oral lesions.Epithelial cell retention of transcriptionally active, P3HR-1-derived heterogeneous Epstein-Barr virus DNA with concurrent loss of parental virus.Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial CellsEpstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epitheliumEpstein-Barr virus infection of Langerhans cell precursors as a mechanism of oral epithelial entry, persistence, and reactivation.Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor originApoptosis in normal and diseased oral tissues.The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuliEpstein-Barr virus in oral diseases.IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3Wild-type Kaposi's sarcoma-associated herpesvirus isolated from the oropharynx of immune-competent individuals has tropism for cultured oral epithelial cells.Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression.Accumulation of cytoplasmic beta-catenin and nuclear glycogen synthase kinase 3beta in Epstein-Barr virus-infected cells.Induction of Epstein-Barr virus latent membrane protein 1 by a lytic transactivator Rta.Design and development of antivirals and intervention strategies against human herpesviruses using high-throughput approach.The Epstein-Barr virus immediate-early protein BZLF1 induces expression of E2F-1 and other proteins involved in cell cycle progression in primary keratinocytes and gastric carcinoma cells.Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria.Epstein-Barr virus in the pathogenesis of oral cancers.Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification.EBV and HHV-6 Circulating Subtypes in People Living with HIV in Burkina Faso, Impact on CD4 T cell count and HIV Viral Load.Oral shedding of herpesviruses in HIV-infected patients with varying degrees of immune status.
P2860
Q24561854-582F313E-EB71-48CE-AB27-14779B57E610Q24563120-30740444-94AD-417C-9943-256D581573C5Q24671870-60358A27-4860-4ED6-BDD2-A46A00735DCBQ26752227-FE677E6A-B4A1-4463-A8AB-FDD344E79A35Q28067117-BC74E410-C688-4B96-A0C6-F1D5DB5B09D8Q28082701-1C48C9E4-4824-4E87-BA67-152C8C4C501EQ28480586-73353B4D-289E-4937-849B-BD9F66691688Q30387268-EF43D585-1650-460E-87AD-C015766B1B8AQ33780975-53551677-4328-4465-9B1C-656FD9760FB5Q33823359-D995FCE0-025A-40CF-8AE8-EEC33FF3AAB2Q33908810-25DB8B14-5E96-4D3C-A1A1-DA9615F5B7CAQ33996858-5C640FBD-EFF6-441E-A2E3-53088C0A3234Q34226611-10A85BD5-E157-4A89-954E-A8A9E195AC4EQ34237606-E2A9DB57-7C36-4D32-8BA7-49BB5AC4968DQ34346421-9F5633A2-90C4-497A-9CC2-A6FF7DF786B0Q34434702-EA4E4E8F-8528-4EBB-8463-2A65E1007D69Q34461528-B52125EB-A3CA-48BB-A647-4DBCEBD4A0DAQ34532370-BCF46282-2433-4117-B8BB-BF582ED508A4Q34581330-5306CF60-E818-4BA9-9874-A5938B222B26Q34775238-D7C9FF8F-9B3D-4486-B265-DAE0418B677EQ35140295-E2A6FC7E-0C7E-4444-87A9-9AF1EAE7B7A9Q35797164-5BDB4779-681D-4B8E-A62E-91D1399C542EQ35857752-C1FDE5D2-7F9C-459F-8CEB-C415930F001BQ35914388-84BEEE8A-73D1-4A74-90ED-9284B3CAB79EQ36124331-66E2D279-0570-4C54-B623-AA4B207396B8Q36239688-1905E26F-3EC3-4DDF-AE06-CA3120E0B0C8Q36414572-25D0F872-CDFF-4B7D-96EB-0FFE83DF662FQ36530296-A2F55E1C-9468-40B5-997B-4B64E9BF833FQ36984994-FFFE943F-CEAE-4ABF-81E5-EEA3FF0E99F4Q37092875-841640DC-4BD3-4720-9091-95096FE5CA33Q37093515-655ECB99-6213-4C72-977E-67F4174EBA12Q37583544-ABD90014-21E5-4C97-9903-2DF1D421D287Q37596540-B425B8E3-5D8D-4337-9E3F-8F3CE51068E5Q38227257-F4D23D08-741B-4D84-AED9-D6CF656FDCACQ38360833-7FA6E2BC-3D8D-49FB-83DA-91BCE25B9D4CQ38366750-53FEF404-74A0-4DF1-B255-3C393A41EDB9Q39132142-68019831-FDDB-4AEA-A089-1666C5F26CD3Q39852028-6523128F-B9B5-4D36-95BB-9CE3DA64B4A0Q40046306-1C1442DE-48D1-40B4-9E87-458BE4BD24A4Q40116637-04F52EB9-0442-40F8-811F-1657DCC07E4A
P2860
Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Hairy leukoplakia: an unusual ...... Epstein-Barr virus infections.
@ast
Hairy leukoplakia: an unusual ...... Epstein-Barr virus infections.
@en
type
label
Hairy leukoplakia: an unusual ...... Epstein-Barr virus infections.
@ast
Hairy leukoplakia: an unusual ...... Epstein-Barr virus infections.
@en
prefLabel
Hairy leukoplakia: an unusual ...... Epstein-Barr virus infections.
@ast
Hairy leukoplakia: an unusual ...... Epstein-Barr virus infections.
@en
P2093
P2860
P1433
P1476
Hairy leukoplakia: an unusual ...... Epstein-Barr virus infections.
@en
P2093
J Middeldorp
J Webster-Cyriaque
N Raab-Traub
P2860
P304
P356
10.1128/JVI.74.16.7610-7618.2000
P577
2000-08-01T00:00:00Z